Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Total Current Liabilities (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Total Current Liabilities for 9 consecutive years, with $970.4 million as the latest value for Q1 2026.

  • For Q1 2026, Total Current Liabilities rose 2.71% year-over-year to $970.4 million; the TTM value through Mar 2026 reached $970.4 million, up 2.71%, while the annual FY2025 figure was $984.5 million, 0.7% up from the prior year.
  • Total Current Liabilities hit $970.4 million in Q1 2026 for Select Medical Holdings, down from $984.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.3 billion in Q2 2024 and bottomed at $939.0 million in Q2 2025.
  • Average Total Current Liabilities over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2024.
  • Year-over-year, Total Current Liabilities grew 8.08% in 2023 and then fell 25.3% in 2025.
  • Select Medical Holdings' Total Current Liabilities stood at $1.2 billion in 2022, then increased by 8.08% to $1.2 billion in 2023, then decreased by 21.69% to $977.7 million in 2024, then increased by 0.7% to $984.5 million in 2025, then dropped by 1.44% to $970.4 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $970.4 million, $984.5 million, and $939.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.